Bahrain has approved the Sinopharm COVID-19 vaccine for children aged between 3 and 11 years, from October 27.
The country's National Medical Taskforce for Combatting the Coronavirus said the decision was taken following a thorough review of all health and safety recommendations.
It also added that the Pfizer COVID-19 vaccine would soon be approved for children between 5 and 11.
The Taskforce stressed that it is important that eligible children get vaccinated to protect themselves, their families, and public health.
Parents can register their children through the Ministry of Health's website or through the BeAware application.
Registration requires the consent of a legal guardian and an adult must accompany the child when receiving the vaccine.
Sinopharm vaccine approved for all children aged 3 to 11https://t.co/AwEJ2fBddb
— Bahrain News Agency (@bna_en) October 26, 2021
Israeli strikes kill 26 in Gaza, health officials say
US government starts likely brief shutdown as House fails to approve deal
Thousands demonstrate in Minnesota and across US to protest ICE
France tightens infant milk rules after recalls
Modi ally proposes social media ban for India's teens as global debate grows
Indonesia landslide death toll rises to 49, agency says
Syrian government, Kurdish-led SDF agree integration deal
Trump warns Britain on China ties as Starmer hails progress in Beijing
